Download PDF
Thromb Haemost 1970; 23(02): 211-227
DOI: 10.1055/s-0038-1654136
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Detection of Fibrinogen Degradation Products by Use of Antibody Coated Latex Particles

The Possibilities and Limits of the Method
E. J Melliger
1   Blood Coagulation and Fibrinolysis Laboratory (Head: PD Dr. F. Duckert) of the University Department of Medicine (Head: Prof. Dr. F. Koller), Bürgerspital, Basel (Switzerland)
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

A method for rapid determination of fibrinogen split products in human blood basing on agglutination of antibody coated latex particles is described. It’s sensitivity corresponds to that of Ouchterlony plates (17 μg/ml plasma). The result is available within 1 hr after drawing of blood. The method is semiquantitative with a at least as good reproducibility as the haemagglutination inhibition method. The reaction kinetics follow the principle of optimal proportion in a precipitin system.

46 healthy people and 36 patients with various diseases were tested with the described method. 3 controls and 12 patients gave positive agglutination reactions that could not be attributed to the presence of split products. The mechanism of these side reactions which could be distinguished from the reactions due to fibrinogen degradation products is discussed. In the plasma of 10 patients split products could be demonstrated by the latex agglutination technic which was also successfully used to control the course of chronic intravascular coagulation in a patient with disseminated cancer of stomach. On account of the obtained results the method can be recommended as a fairly sensitive screening test for rapid bedside detection of fibrinogen degradation products.

 

  • References

  • 1 Seegers W. H, Nieft M. L, Vandenbelt J. M. Decomposition products of fibrinogen and fibrin. Arch. Biochem 7: 15 1945;
    PubMedSearch in Google Scholar
  • 2 Niewiarowski S, Kowalski E. Formation of an antithrombin like anticoagulant during proteolysis of fibrinogen. Bull. Acad. poi. Sci. Ser. Sc. Biol 5: 169 1957;
    PubMedSearch in Google Scholar
  • 3 Niewiarowski S, Kowalski E. Un nouvel anticoagulant dérivé du fibrinogène. Rév. Hémat 13: 321 1958;
    PubMedSearch in Google Scholar
  • 4 Triantaphyllopoulos D. G. Anticoagulant effect of incubated fibrinogen. Canad. J. Biochem 515: 249 1958;
    PubMedSearch in Google Scholar
  • 5 Gajewski J, Alexander B. Effect of plasmin on fibrinogen an fibrin. Amer. J. Physiol 209: 79 1964;
    PubMedSearch in Google Scholar
  • 6 Ferguson H. J. Assay of tryptase by lysis of fibrinogen. Proc. Soc. exp. Biol. (N. Y.) 52: 243 1943;
    CrossrefPubMedSearch in Google Scholar
  • 7 Pechet L, Alexander B. The effect of certain proteolytic enzymes on the thrombin-fibrinogen interaction. Biochemistry 1: 875 1962;
    CrossrefPubMedSearch in Google Scholar
  • 8 Bocha E, Silva M, Andrade S. O, Teixeira B. M. Coagulation defect in the shocks produced by trypsin, peptone and ascaris extracts. Exp. Med. Surg 4: 260 1946;
    PubMedSearch in Google Scholar
  • 9 Barnhardt M. I. Importance of neutrophilic leukocytes in the resolution of fibrin. Fed. Proc 24: 846 1965;
    PubMedSearch in Google Scholar
  • 10 Batnoff O. D. Studies on a proteolytic enzyme in human plasma: IV. The rate of lysis of plasma clots in normal and diseased individuals, with particular reference to hepatic disease. :Bull. Johns Hopk. Hosp 84: 29 1949;
    PubMedSearch in Google Scholar
  • 11 Beaumont J. L, Beaumont V, Domart A. Recherches sur l’activité fibrinolytique spontanée du plasma dans les cirrhoses du foie. Rév. franç. Étud. clin. biol 1: 667 1956;
    PubMedSearch in Google Scholar
  • 12 Sherry S, Lindemeyer R. I, Fletcher A. P, Alkjaersig N. Studies on enhanced fibrinolytic activity in man. J. clin. Invest 38: 810 1959;
    CrossrefPubMedSearch in Google Scholar
  • 13 Fearnley G. R, Ghakrabarti R. Pharmacological enhancement of fibrinolytic activity of blood. J. clin. Path 17: 328 1964;
    CrossrefPubMedSearch in Google Scholar
  • 14 Schneider G. L. Fibrination and defibrination, in: Physiologie und Pathologie der Blutgerinnung in der Gestationsperiode. F. K. Schattauer; Stuttgart: 1957
    Search in Google Scholar
  • 15 Pritchard J. A, Wright M. R. Pathogenesis of hypofibrinogenemia in placental abruption. New Engl. J. Med 261: 218 1959;
    CrossrefPubMedSearch in Google Scholar
  • 16 Soldier J. P, Mathey J, Le Bollock A. G, Daumet P, Fayet H. Syndromes hémorrhagiques mortels avec incoagulabilité totale par défibrination et avec fibrinolyse. 1. Au cours des exérèses pulmonaires. Rév. Hémat 7: 30 1952;
    PubMedSearch in Google Scholar
  • 17 Bernard J, Mathé G, Boulay J, Ceoara B, Chomé J. La leucose aigue à promyelocytes. Etude portant sur 20 observations. Schweiz, med. Wschr 89: 604 1959;
    PubMedSearch in Google Scholar
  • 18 Baker W. G, Bang N. U, Nachman R. L, Raafat F, Horowitz H. I. Hypofibrinogenemic hemorrhage in acute myelogenous leukemia treated with heparin. With autopsy findings of widespread intravascular clotting. Ann. intern. Med 61: 116 1964;
    CrossrefPubMedSearch in Google Scholar
  • 19 Verstraete M, Vermylen G, Vermylen J, Vandenbroucke J. Excessive consumption of blood coagulation components as cause of hemorrhagic diathesis. Amer. J. Med 38: 899 1965;
    CrossrefPubMedSearch in Google Scholar
  • 20 Tagnon H. J, Shulman P, Whitmore W. F, Kravitz S. C. The “hemorrhagic syndrome of metastatic prostatic cancer and it’s treatment. J. clin. Invest 31: 666 1952;
    PubMedSearch in Google Scholar
  • 21 Zeh H, Ott H. Klinische Gesichtspunkte zur Entstehung der erworbenen Afibrinogenämie und Fibrinogenopenie mit hämorrhagischer Diathese. Acta haemat. (Basel) 12: 106 1954;
    CrossrefPubMedSearch in Google Scholar
  • 22 Frick P. G. Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer. Acta haemat. (Basel) 16: 12 1956;
    PubMedSearch in Google Scholar
  • 23 Meikle W. A, Graybill J. R. Fibrinolysis and hemorrhage in a fatal case of heat stroke. New Engl. J.Med 276: 911 1967;
    PubMedSearch in Google Scholar
  • 24 Ferreira H. C, Murat L. G. An immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states. Brit. J. Haemat 9: 299 1963;
    CrossrefPubMedSearch in Google Scholar
  • 25 Nhehn J.-E, Nilsson I. M. Demonstration of fibrinolytic split products in human serum by an immunological method in spontaneous and induced fibrinolytic states. Scand. J. Haemat 1: 313 1964;
    PubMedSearch in Google Scholar
  • 26 Merskey C, Kleiner G. J, Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 28: 1 1966;
    PubMedSearch in Google Scholar
  • 27 Brinkhous K. M, Wright I. S, Koller F, Streuli F, Duckert F. (Ed.) Diffuse intravascular clotting. F. K. Schattauer; Stuttgart: 1969
    Search in Google Scholar
  • 28 Catt K. J, Hirsh J, Castelan D. J, Niall H. D, Tregear G. I. F. Radioimmunoassay of fibrinogen and its proteolysis products. Thrombos. Diathes. haemorrh. (Stuttg.) 20: 1 1968;
    PubMedSearch in Google Scholar
  • 29 Nussenzweig V, Seligmann M, Pelmont J, Grabar P. Les produits de dégradation du fibrinogène humain par la plasmine. I. Séparation et propriétés physiochimiques. Ann. Inst. Pasteur 200: 377 1961;
    PubMedSearch in Google Scholar
  • 30 Lewis J. H, Wilson J. H. Fibrinogen breakdown products. Amer. J. Physiol 207: 1053 1964;
    PubMedSearch in Google Scholar
  • 31 Fletcher A. P, Alkjaersig N, Fisher S, Sherry S. The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen dervatives which polymerize abnormally. J. Lab. clin. Med 68: 780 1966;
    PubMedSearch in Google Scholar
  • 32 Niléhn J.-E. Split products of fibrinogen after prolonged interaction with plasmin. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 89 1967;
    PubMedSearch in Google Scholar
  • 33 Triantaphyllopoidos E, and Triantaphyllopoulos D. C. Micromolecular fragments split from fibrinogen. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 300 1967;
    PubMedSearch in Google Scholar
  • 34 Kowalski E, Kopeć M, Wegrzynowicz Z. Influence of fibrinogen degradation products (FDP) on platelet aggregation, adhesiveness and viscous metamorphosis. Thrombos. Diathes. haemorrh. (Stuttg.) 10: 406 1964;
    PubMedSearch in Google Scholar
  • 35 Jerushalmy Z, Zucker M. B. Some effects of fibrinogen degradation products (FDP) on blood platelets. Thrombos. Diathes. haemorrh. (Stuttg.) 15: 413 1966;
    PubMedSearch in Google Scholar
  • 36 Kopeć M, Budzyński A, Stachurska J, Wegrzynowicz Z, Kowalski E. Studies on mechanism of interference by fibrinogen degradation products (FDP) with platelet function: role of fibrinogen in platelet atmosphere. Thrombos. Diathes. haemorrh. (Stuttg.) 15: 476 1966;
    PubMedSearch in Google Scholar
  • 37 Niewiarowski S, Batallo Z, Stachurska J. Apparition d’un inhibiteur de la thromboplastino-formation au cours de la protéolyse du fibrinogène. Rév. Hémat 14: 118 1959;
    PubMedSearch in Google Scholar
  • 38 Triantaphyllopoulos D. C, Triantaphyllopoulos E. Evidence of antithrombic activity of the anticoagulant fraction of incubated fibrinogen. Brit. J. Haemat 12: 145 1966;
    CrossrefPubMedSearch in Google Scholar
  • 39 Alkjaersig N, Fletcher A. P, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. II. The significance, mechanism and consequences of defective fibrin polymerization. J. clin. Invest 41: 917 1962;
    CrossrefPubMedSearch in Google Scholar
  • 40 Salmon J. Étude immunochimique du fibrinogène et de ses dérivés. Clin. chim. Acta 4: 767 1959;
    CrossrefPubMedSearch in Google Scholar
  • 41 Nussenzweig V, Seligmann M. Analyse par des méthodes immunochimiques, de la dégradation par la plasmine du fibrinogène humain et de la fibrine a différantes stades. Rév. Hémat 15: 451 1960;
    PubMedSearch in Google Scholar
  • 42 Nussenzweig V, Seligmann M, Grabar P. Les produits de dégradation du fibrinogène humain par la plasmine. II. Étude immunochimique: mise en évidence d’anticorps antifibri-nogène natif possédant des spécifités différantes. Ann. Inst. Pasteur 100: 491 1961;
    PubMedSearch in Google Scholar
  • 43 Niléhn J. E. Separation and estimation of “split products” of fibrinogen and fibrin in human serum. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 487 1967;
    PubMedSearch in Google Scholar
  • 44 Lipiński B, Wegrzynowicz Z, Budzyński A. Z, Kopeć M, Batallo Z. S, Kowalski E. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Thrombos. Diathes. haemorrh. (Stuttg.) 17: 65 1967;
    PubMedSearch in Google Scholar
  • 45 Fox Jr. F. J, Wide L, Killander J, Gemzell G. Determination of fibrinogen and fibrinolysis products in human plasma by an immunological method. Scand. J. clin. Lab. Invest 17: 341 1965;
    CrossrefPubMedSearch in Google Scholar
  • 46 Ouchterlony O. Antigen-antibody reactions in gels. Acta pathol. microbiol. scand 26: 507 1949;
    PubMedSearch in Google Scholar
  • 47 Scheidegger J. J. Une microméthode de l’immunoelectrophorèse. Int. Arch. Allergy 7: 103 1955;
    CrossrefPubMedSearch in Google Scholar
  • 48 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel) 17: 237 1957;
    CrossrefPubMedSearch in Google Scholar
  • 49 Gitlin D. Use of ultraviolet absorbtion spectroscopy in the quantitative precipitin reaction. J. Immunology 62: 437 1949;
    PubMedSearch in Google Scholar
  • 50 Nichol J. G, Deutsch H. F. Biophysical studies of blood plasma proteins. VII. Separation of gammaglobulins from the sera of various animals. J. Amer. ehem. Soc 70: 80 1948;
    CrossrefPubMedSearch in Google Scholar
  • 51 Campbell D. H, Garvey J. S, Cremer N. E, Sussdorf D. H. (Ed.) Methods in Immunology. W. A. Benjamin Inc.; New York, Amsterdam: 1964
    Search in Google Scholar
  • 52 Singer J. M, Plotz C. M. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Amer. J. Med 21: 88 1956;
    PubMedSearch in Google Scholar
  • 53 Singer J. M, Altmann G, Oreskes J, Plotz C. M. The mechanism of paticulate carrier reactions. III. The stabilizing effect of serum proteins. Amer. J. Med 30: 772 1961;
    CrossrefPubMedSearch in Google Scholar
  • 54 Dean H. R, Webb R. A. The influence of optimal proportions of antigen and antibody in the serum precipitation reaction. J. Path. Bact 29: 473 1926;
    CrossrefPubMedSearch in Google Scholar
  • 55 Isizaka T, Isizaka K. Biological activities of aggregated gamma globulin I. Skin reactive and complement-fixing properties of heat denaturated gammaglobulin. Proc. Soc. exper. Biol. (N. Y.) 101: 845 1959;
    CrossrefPubMedSearch in Google Scholar
  • 56 Singer J. M, Altmann G, Goldenberg A, Plotz C. M. The mechanism of particulate carrier reactions with rheumatoid sera. II. Sensitizing capacity of various human gamma globulins for latex paticles. Arthr. Rheum 3: 515 1960;
    CrossrefPubMedSearch in Google Scholar
  • 57 Dresner E, Trombly P. The latex-fixation reaction in non-rheumatic diseases. New. Engl. J. Med 261: 981 1959;
    CrossrefPubMedSearch in Google Scholar
  • 58 Howell D. S, Malcolm J. M, Rike P. The F-II-agglutinating factors in serums of patients with non-rheumatic diseases. Amer. J. Med 29: 662 1960;
    CrossrefPubMedSearch in Google Scholar
  • 59 Bartfeld H. Incidence and significance of seropositive tests for rheumatoid factor in non-rheumatic disease. Ann. intern. Med 52: 1059 1960;
    CrossrefPubMedSearch in Google Scholar
  • 60 Ropartz C, Memet Y, Hurei R, Lenoir J. Présence d’une antiglobuline humaine dans le serum de sujets tuberculeux. Rév. franç. Étud. clin. Biol 3: 1083 1958;
    PubMedSearch in Google Scholar
  • 61 Singer J. M, Plotz C. M, Peralta F. M, Lyons H. C. Presence of anti-gamma globulin factors in sera of patients with active pulmonary tuberculosis. Ann. int. Med 56: 545 1962;
    CrossrefPubMedSearch in Google Scholar
  • 62 Harter F, Dickgiesser F. Agglutination reactions with sensitized erythrocytes in chronic polyarthritis and other diseases. Deutsch. Arch, kl in. Med 200: 202 1953;
    PubMedSearch in Google Scholar
  • 63 Peltier A, Christian C. L. The presence of the “rheumatoid factor” in sera from patients with syphilis. Arthr. and Rheum 2: 1 1959;
    CrossrefPubMedSearch in Google Scholar
  • 64 Cathcart E. S, Williams Jr. R. C, Ross S. H, Calkins E. Relationship of the latex fixation test to the clinical and serological manifestations of leprosy. Amer. J. Med 31: 758 1961;
    CrossrefPubMedSearch in Google Scholar
  • 65 Dresner E, Trombly P, O’Brien G. F. Latex fixation in nonrheumatic diseases. Clin. Res 7: 49 1959;
    PubMedSearch in Google Scholar
  • 66 Ziff M. The agglutination reaction in rheumatoid arthritis. J. chron. Dis 5: 644 1957;
    CrossrefPubMedSearch in Google Scholar
  • 67 Williams R. C, Kunkel H. G. Rheumatoid factor, complement and conglutinin aberrations in patients with subacute bacterial endocarditis. J. clin. Invest 41: 666 1962;
    CrossrefPubMedSearch in Google Scholar
  • 68 Kunkel H. G, Simon H. J, Fudenberg H. Observations concerning positive serologic reactions for rheumatoid factor in certain patients with sarcoidosis and other hyperglobulinaemic states. Arthr. and Rheum 1: 289 1958;
    CrossrefPubMedSearch in Google Scholar
  • 69 Vierucci A. Gm groups and anti-Cm antibodies in children with Cooley’s anaemia. Vox Sang. (Basel) 10: 82 1965;
    PubMedSearch in Google Scholar
  • 70 Ropartz C, Vierucci A, Rivat L, Rousseau P.-Y. Simultaneous presence of ant i-Gm and anti-Inv in a poly transfused patient. Rév. franç. Étud. clin. Biol 9: 977 1964;
    PubMedSearch in Google Scholar
  • 71 Allen J. C, Kunkel H. G. Antibodies against gammaglobulin after repeated blood transfusions in man. J. clin. Invest 45: 29 1966;
    CrossrefPubMedSearch in Google Scholar
  • 72 Speiser P. Über Antikörperbildung von Säuglingen und Kleinkindern gegen mütterliches gamma-2-Globulin. Ein bisher unbekanntes, dem Erythroblastosemechanismus konträres Phänomen mit anscheinend immunogenetisch obligatem Charakter. Wien. med. Wschr 113: 966 1963;
    PubMedSearch in Google Scholar
  • 73 Steinberg A, Wilson J. A. Hereditary globulin factors and immunotolerance in man. Science 140: 303 1963;
    CrossrefPubMedSearch in Google Scholar
  • 74 L’Oudin J. “Allotypic” de certains antigènes protéidiques du sérum. C. R. Ac ad. Sci. (Paris) 242: 2606 1956;
    PubMedSearch in Google Scholar